Seth Klarman - Baupost Group
Holding/activity history for Akebia Therapeutics, Inc. (AKBA)
← All AKBA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q3 | 0 | 0.00 | Sell 100.00% | 2.55 | $2.34–13.71 · VW $6.04i | SEC | |
| 2020 Q2 | 15,000,000 | 2.55 | Reduce 14.42% | 0.28 | $6.37–13.68 · VW $10.90i | $203,700,000 | SEC |
| 2020 Q1 | 17,527,968 | 1.97 | Reduce 10.44% | 0.15 | $3.81–10.53 · VW $7.67i | $132,862,000 | SEC |
| 2019 Q4 | 19,571,453 | 1.44 | Reduce 20.02% | 0.24 | $2.99–6.96 · VW $5.38i | $123,692,000 | SEC |
| 2019 Q3 | 24,471,453 | 1.20 | $3.92 | $95,928,000 | SEC | ||
| 2019 Q2 | 24,471,453 | 1.16 | $4.84 | $118,442,000 | SEC | ||
| 2019 Q1 | 24,471,453 | 1.80 | $8.19 | $200,421,000 | SEC | ||
| 2018 Q4 | 24,471,453 | 1.23 | Buy | 1.23 | $5.20–10.45 · VW $7.60i | $135,327,000 | SEC |
Price snapshot:
Current price$1.38
52-week low$0.82
52-week high$4.04